The steroid receptor coactivator, GRIP-1, is necessary for MEF-2C- dependent gene expression and skeletal muscle differentiation

Genes and Development

Volumn 14, Issue 10, 2000, Pages 1209-1228

  Chen, Shen Liang ^a   Dowhan, Dennis H ^b   Hosking, Brett M ^a   Muscat, George E O ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Gene expression; GRIP 1; Myogenic cells; Skeletal muscle differentiation

Indexed keywords

HELIX LOOP HELIX PROTEIN; MESSENGER RNA; MYOGENIN; PROTEIN GRIP 1; PROTEIN MEF 2C; PROTEIN P21; PROTEIN P300; STEROID RECEPTOR COACTIVATOR 1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CHROMATIN; CONTROLLED STUDY; GENE EXPRESSION REGULATION; IMMUNOPRECIPITATION; MUSCLE DEVELOPMENT; MYOBLAST; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; RNA ANALYSIS; SKELETAL MUSCLE; TRANSACTIVATION; TRANSCRIPTION REGULATION;

ANIMALS; BINDING SITES; CELL DIFFERENTIATION; CELL LINE; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HELIX-LOOP-HELIX MOTIFS; HUMANS; MADS DOMAIN PROTEINS; MICE; MUSCLE, SKELETAL; MYOGENIC REGULATORY FACTORS; MYOGENIN; NUCLEAR RECEPTOR COACTIVATOR 2; ORGAN SPECIFICITY; PRECIPITIN TESTS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; RESPONSE ELEMENTS; RNA, ANTISENSE; RNA, MESSENGER; SEQUENCE DELETION; TCF TRANSCRIPTION FACTORS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TWO-HYBRID SYSTEM TECHNIQUES;

ANIMALIA; MAMMALIA;

EID: 0034658463     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Anzick, S.L., J. Kononen, R.L. Walker, D.O. Azorsa, M.M. Tanner, X.Y. Guan, G. Sauter, O.P. Kailioniemi, J.M. Trent, and P.S. Meltzer. 1997. AlB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Nature 277: 965-968.
2. Bailey, P., M. Downes, P. Lau, J. Harris, S.L. Chen, Y. Hamamori, V. Sartorelli, and G.E. Muscat. 1999. The nuclear receptor corepressor N-CoR regulates differentiation: N-CoR directly interacts with MyoD. Mol. Endocrinol. 13: 11551168.
3. Black, B.L., J. Molkentin, and E.N. Olson. 1998. Multiple roles for the MyoD basic region in transmission of transcriptional activation signals and interaction with MEF2. Mol. Cell. Biol 18: 69-77.
4. Bour, B.A., M.A. O'Brien, W.L. Lockwood, E.S. Goldstein, R. Bodner, P.H. Taghert, S.M. Abmayr, and H.T. Nguyen. 1995. Drosophila MEF-2C, a transcription factor required for myogenesis. Genes & Dev. 9: 730-741.
5. Brehm, A., E.A. Miska, D.J. McCance, J.L. Reid, A.J. Bannister, and T. Kouzarides. 1998. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391: 597-601.
6. Burke, L., M. Downes, A. Carozzi, V. Giguere, and G.E. Muscat. 1996. Nucleic Acids Res. 24: 3481-3489.
7. Casanova, J., E. Helmer, S. Selmi-Ruby, J.-S. Qi, M. Au-Fliegner, V. Desai-Yajnik, N. Koudinova, F. Yarm, B.M. Raaka, and H.H. Samuels. 1994. Functional evidence for ligand-dependent dissociation of thyroid hormone and retinoic acid receptors from an inhibitory cellular factor. mol. Cell. Biol. 14: 5756-5765.
8. Chen, D., H. Ma, H. Hong, S.S. Koh, S.M. Huang, B.T. Schurter, D.W. Aswad, and M.R. Stallcut. 1999. Regulation of transcription by a protein methyltransferase. Science 284: 2174-2177.
9. Chen, H., R.J. Lin, R.L. Schitz, D. Chakravarti, A. Nash, L. Nagy, M.L. Privalsky, Y. Nakatani, and R.M. Evans. 1997. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90: 569-580.
10. Crews, S.T. and C.-M. Fan. 1999. Remberance of things PAS: Regulation of development by bHLH-PAS proteins. Curr. Opin. Genet, Dev. 9: 580-587.
11. Cserjesi, P. and E.N. Olson. 1991. Myogenin induces muscle specific enhancer binding factor MEF-2 independently of other muscle specific gene products. Mol. Cell. Biol 11: 4854-4862.
12. Downes, M., A.J. Carozzi, and G.E. Muscat. 1995. Constitutive expression of the orphan receptor, Rev-erbA alpha, inhibits muscle differentiation and abrogates the expression of the myoD gene family. Mol. Endocrinol. 9: 1666-1678.
13. Eckner, R., T.P. Yao, E. Oldread, and D.M. Livingston. 1996. Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation. Genes & Dev. 10: 2478-2490.
14. Edmondson, D.G. and E.N. Olson. 1989. A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program. Genes & Dev. 3: 628-640.
15. Ferreira, R., L. Maghaghi-Jaulin, P. Robin, A. Harel-Bellan, and D. Trouche. 1998. The three members of the pocket proteins family share the ability to repress E2F activity through recruitment of a histone deactylase. Proc. Natl. Acad. Sci. 95: 10493-10498.
16. Glass, C.K. and M.G. Rosenfeld. 2000. The coregulator exchange in transcriptional functions of nuclear receptors. Genes & Dev. 9: 140-147.
17. Gossett, L.A., D.J. Kelvin, E.A. Sternberg, and E.N. Olson. 1989. A new myocyte specific enhancer binding factor that recognizes a conserved element associated with muscle specific genes. Mol. Cell. Biol 9: 5022-5033.
18. Gu, W., J.W. Schneider, G. Condorelli, S. Kaushal, V. Mahdavi, and B. Nadal-Ginard. 1993. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72: 309-324.
19. Guo, K. and K. Walsh. 1997. Inhibition of myogenesis by multiple cyclin-cdk complexes. J. Biol. Chem. 272: 791-797.
20. Guo, K., J. Wang, V. Andres, R.C. Smith, and K. Walsh. 1995. MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol. Cell. Biol. 15: 3823-3829.
21. Halevy, O., B.G. Novitch, D.B. Spicer, S.X. Skapek, J. Rhee, G.J. Hannun, D. Beach, and A.B. Lassar. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267: 1018-1021.
22. Hamamori, Y., V. Sartorelli, V. Ogryzko, P.L. Puri, H.-Y. Wu, J. Wang, Y. Nakatani, and L. Kedes. 1999. Regulation of histone acetyltransferases, p300 and PCAF, by the bHLH protein twist and adenoviral oncoprotein E1A. Cell 96: 405-413.
23. Hasty, P., A. Bradley, J. Morris, D. Edmondson, J. Venutti, E. Olson, and W. Klein. 1993. Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature 364: 501-506.
24. Henthorn, P., M. Kiledjian, and T. Kadesch. 1990. Two distinct transcription factors that bind the immunoglobulin enhancer uE5/KE2. Science 247: 467-470.
25. Hong, H., K. Kohli, A. Trwedi, D.L. Johnson, and M.R. Stallcup. 1996. GRIP-1 a novel mouse protein that serves as transcnptional coactivator in yeast for the hormone binding domains of steroid receprtors. Proc. Natl. Acad. Sci. 93: 4946-4952.
26. Kadesch, T. 1993. Consequences of heteromeric interactions among helix loop helix proteins. Cell Growth Diff. 4: 49-55.
27. Kamei, Y., L. Xu, T. Heinzel, J. Torchia, R. Kurokawa, B. Gloss, S.C. Lin, R. Heyman, D.W. Rose, C.K. Glass, and M.G. Rosenfeld. 1996. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85: 403-414.
28. Kiess, M., M. Gill, and P. Hamel. 1995. Expression and activation of the retinoblastoma protein (pRb)-family proteins, p107 and p130 during L6 myoblast differentiation. Cell Growth Differ. 6: 1287-1298.
29. Lassar, A.B., R.L. Davis, W.E. Wright, T. Kadesch, C. Murre, A. Voronova, D. Baltimore, and H. Weintraub. 1991. Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo. Cell 66: 305-315.
30. Li, H., P.J. Gomes, and J.D. Chen. 1997. RAC-3, a steroid receptor associated coactivator that is related to SRC-1 and RAC-3. Proc. Natl. Acad. Sci. 94: 8479-8484.
31. Ludolph, D. and S. Koniesczny. 1995. Transcription factor families: Muscling in on the myogenic program. FASEB J. 9: 1595-1604.
32. Magnaghi-Jaulin, L., R. Groisman, I. Naguibneva, P. Robin, S. Lorain, J.P. Le Villain, F. Troalen, D. Trouche, and A. HarelBellan. 1998. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391: 601-605.
33. McKenna, N.J., R.B. Lanz, and B.W. O'Malley. 1999. Nuclear receptor coregulators: Cellular and molecular biology. Endoc. Rev. 20: 321-344.
34. Miska, E., C. Karlsson, E. Langley, S.J. Nielson, J. Pines, and T. Kouzarides. 1999. HDAc4 deacetylase associates with and represses the MEF-2 transcription factor. EMBO J. 18: 5099-5107.
35. Molkentin, J.D. and E.N. Olson. 1996. Defining the regulatory network for muscle development. Curr. Opin. Genet. Dev. 6: 445-453.
36. Molkentin, J., B.L. Black, J.F. Martin, and E.N. Olson. 1995. Cooperative activation of muscle gene expression by MEF-2 and myogenic bHLH proteins. Cell 83: 1125-1136.
37. _. 1996. Mutational analysis of the DNA binding, dimerization and transcriptional activation domains of MEF-2C. Mol. Cell. Biol. 16: 2627-2636.
38. Moras, D. and H. Gronemeyer. 1998. The nuclear receptor ligand binding domain: Structure and function. Curr. Opin. Cell Biol. 10: 384-391.
39. Murre, C., A. Voronova, and D. Baltimore. 1991. B-cell and myocyte specific E2-box binding factors binding factors contain E12/E47-like subunits. Mol. Cell. Biol. 11: 1156-1160.
40. Muscat, G.E., S. Rea, and M. Downes. 1995. Identification of a regulatory function for an orphan receptor in muscle: COUP-TF II affects the expression of the myoD gene family during myogenesis.Nucfeic Acids Res. 23: 1311-1318.
41. Na, S.Y., S.S.K. Lee, S.J. Han, H.S. Choi, S.S.Y. Im, and J.W. Lee. 1998. Steroid receptor coactivator-1 interacts with the p50 subunit and coactivates nuclear factor kappaB-mediated transactivation. J. Biol Chem. 2273: 10831-10834.
42. Novitch, B.C., G.J. Mulligan, T. Jacks, and A.B. Lassar. 1996. Skeletal muscle cells lacking the retinoblastoma protein display defects in muscle gene expression and accumulate in S and G2 phases of the cell cyle. J. Cell Biol. 135: 441-456.
43. Novitch, B.G., D.B. Spicer, P.S. Kim, W.L. Cheung, and A.B. Lassar. 1999. pRb is required for MEF-2 dependent gene expression as well as cell cycle arrest during skeletal muscle differentiation. Curr. Biol. 9: 449-459.
44. Olson, E.N. 1992. Interplay between proliferation and differentiation within the myogenic lineage. Dev. Biol. 154: 261-272.
45. Olson, E.N., H.H. Arnold, P.W. Rigby, and B.J. Wold. 1996. Know your neighbors: Three phenotypes in null mutants of the myogenic bHLH gene MRF4. Cell 85: 1-4.
46. Olson, E.N. and W.H. Klein. 1994. bHLH factors in muscle development: Dead lines and commitments, what to leave in and what to leave out. Genes & Dev. 8: 1-8.
47. Onate, S.A., S.Y. Tsai, M.J. Tsai, and B.W. O'Malley. 1995. Sequence and characterization of a coactivator for the steroid receptor superfamily. Science 270: 1354-1357.
48. Parker, S.B., G. Eichele, P. Zhang, A. Rawls, A.T. Sands, A. Bradley, E.N. Olson, J.W. Harper, and S.J. Elledge. 1995. p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science 267: 1024-1027.
49. Puri, P.L., M.L. Avantaggiati, C. Balsano, N. Sang, A. Graessmann, A. Giordano, and M. Levrero. 1997a. p300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcription. EMBO J. 16: 369-383.
50. Puri, P.L., V. Sartorelli, X. Yang, Y. Hamamori, V.V. Ogryzko, B.H. Howard, L. Kedcs, J.Y.L. Wang, A. Graessmann, Y. Nakatani, and M. Levrero. 1997b. PCAF histone acetyl transferase promotes muscle differentiation. Mol. Cell 1: 35-45.
51. Rudnicki, M., P. Schnegelsberg, R. Stead, T. Braun, H.-H. Arnold, and R. Jaenisch. 1993. MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 75: 1351-1359.
52. Sartorelli, V., J. Huang, Y. Hamamori, and L. Kedes. 1997. Molecular mechanisms of myogenic coactivation by p300: Direct interaction with the activation domain of MyoD and with the MADS box of MEF2C. Mol. Cell. Biol. 17: 1010-1026.
53. -/- muscle cells. Science 264: 1467-1471.
54. Skapek, S.X., J. Rhee, D.B. Spicer, and A.B. Lasser. 1995. Inhibition of myogenic differentiation in proliferating myoblasts by cyclinD1-dependant kinase. Science 267: 1022-1024.
55. Skapek, S.X., J. Rhee, P.S. Kim, B.G. Novitch, and A.B. Lasser. 1996. Cyclin-mediated inhibition of muscle gene expression via a mechanism that is indépendant of pRB hyperphosphorylation. Mol. Cell. Biol. 16: 7043-7053.
56. Sparrow, D.B., E.A. Miska, E. Langley, S.R. Deonauth, A.S. Kotecha, N. Towers, G. Spohr, T. Kouzaridies, and T.J. Mohun. 1999. MEF-2 function is modified by a novel co-repressor, MITR. EMBO J. 18: 5085-5098.
57. Spicer, D.B., J. Rhee, W.L. Cheung, and A.B. Lassar. 1996. Inhibition of myogenic bHLH and MEF-2 transcription factors by the bHLH protein, twist. Science 272: 1476-1480.
58. Suen, C.S., T.J. Berrodin, R. Mastroeni, B.J. Cheskis, C.R. Lytlle, and D.E. Frail. 1998. A transcriptional coactivator, SRC-3, selectively augments steroid receptor activity. J. Biol. Chem. 273: 27645-27653.
59. Sun, X.-H. and D. Baltimore. 1991. An inhibitory domain of E12 transcription factor prevents DNA binding in E12 homodimers, but not in E12 heterodimers. Cell 64: 459-470.
60. Takeshita, A., G.R. Cardona, N. Koibuchi, C.S. Suen, and W.W. Chin. 1997. TRAM-1, a novel 160-kDa thyroid hormone receptor activator molecule, exhibits distinct properties from SRC-1. J. Biol. Chem. 272: 27629-27634.
61. Tapscott, S.J. and H. Weintraub. 1991. MyoD and the regulation of myogenesis by helix-loop-helix proteins. J. Clin. Invest. 87: 1133-1138.
62. Torchia, J., D.W. Rose, J. Inostroza, Y. Kamei, S. Westin, C.K. Glass, and M.G. Rosenfeld. 1997. The transcritional coactivator pCIP binds CBP and mediates nuclear receptor function. Nature 387: 677-684.
63. Trouche, D., A. Cook, and T. Kouzarides. 1996. The CBP coactivator stimulates E2F1/DP1 activity. Nucleic Acids Res. 24: 4139-4145.
64. Umesono, K., K.K. Murakami, C.C. Thompson, and R.M. Evans. 1991. Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell 65: 1255-1266.
65. Voegel, J., M. Heine, C. Zechel, P. Chambon, and H. Gronemeyer. 1996. TIF2, a 160 kDa transcriptional mediator for the ligand dependent activation function AF-2 of nuclear receptors. EMBO J. 15: 3667-3675.
66. Walsh, K. and H. Perlman. 1997. Cell cycle exit upon myogenic differentiation. Curr. Opin. Genet. Dev. 7: 597-602.
67. Wang, A.H., N.R. Bertos, M. Vezmar, N. Pelletier, M. Crosato, H.H. Heng, J.T.-H. Ng, J. Han, and X.-J. Yang. 1999. HDAC4, a human histone deacetylase related to HDA1, is a transcriptional corepressor. Mol. Cell. Biol. 19: 7816-7827.
68. Weintraub, H., V.J. Dwarki, I. Verma, R. Davis, S. Hollenberg, L. Snider, A. Lassar, and S.J. Tapscott. 1991. Muscle-specific transcriptional activation by MyoD. Genes & Dev. 5: 1377-1386.
69. Westin, S., R. Kurokawa, R.T. Nolte, G.B. Wisely, E.M. McInerney, D.W. Rose, M.V. Milburn, M.G. Rosenfeld, and C.K. Glass. 1998. Interactions controlling the assembly of nuclear receptor heterodimers and coactivators. Nature 395: 199-202.
70. Willy, P.J., K. Umesono, E.S. Ong, R.M. Evans, R.A. Heyman, and D.J. Mangelsdorf. 1995. LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes & Dev. 9: 1033-1045.
71. Xu, L., C.K. Glass, and M.G. Rosenfeld. 1999. Coactivator and corepressor complexes in nuclear receptor function. Curr. Opin. Genet. Dev. 9: 140-147.
72. Yun, K. and B. Wold. 1996. Skeletal muscle determination and differentiation: Story of a core regulatory network and its context. Curr. Opin. Cell Biol. 8: 877-889.
73. Zacksenhaus, E., Z. Jiang, D. Chung, J.D. Marth, R.A. Phillips, and B.L. Gallie. 1996. pRb controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis. Genes & Dev. 10: 3051-3064.